Tokyo, Japan

Kazuteru Aoki

This inventor holds 2 USPTO granted patents. Top assignee: Ribomic Inc.. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazuteru Aoki. Retrieved from https://idiyas.com/inventor/kazuteru-aoki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2022-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kazuteru Aoki: Innovator in Aptamer Technology

Introduction

Kazuteru Aoki is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of aptamers. His work focuses on innovative solutions that address critical medical challenges.

Latest Patents

Kazuteru Aoki holds a patent for an aptamer designed for ADAMTS5, a disintegrin and metalloproteinase with thrombospondin motifs-5. The patent details an aptamer containing a specific sequence that binds to ADAMTS5, which has potential applications in therapeutic interventions. This invention is crucial for advancing treatments related to various diseases.

Career Highlights

Aoki is associated with Ribomic Inc., a company that specializes in aptamer technology. His role at Ribomic has allowed him to further his research and development efforts in this innovative field. With a focus on practical applications, Aoki's work is paving the way for new therapeutic options.

Collaborations

[This section has been skipped due to space constraints.]

Conclusion

Kazuteru Aoki's contributions to aptamer technology exemplify the innovative spirit of modern biotechnology. His patent for an aptamer targeting ADAMTS5 showcases his commitment to advancing medical science. Aoki's work continues to inspire future developments in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…